Successful treatment of osseous blastomycosis without pulmonary or disseminated disease and review of the literature

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 2, 2014, Pages 242-244

  Day, Shandra R ^a   Weiss, David B ^a   Hazen, Kevin C ^b   Moore, Christopher C ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blastomycosis; Cutaneous inoculation; Orthopedic infection

Indexed keywords

ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; TRIAZOLE DERIVATIVE;

ADULT; ARTICLE; BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; BONE INFECTION; CASE REPORT; CLINICAL FEATURE; DNA SEQUENCE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FUNGUS CULTURE; HUMAN; LIVER TOXICITY; LUNG DISEASE; MALE; MIDDLE AGED; NONHUMAN; OSSEOUS BLASTOMYCOSIS; PRIORITY JOURNAL; SYSTEMIC DISEASE; BLASTOMYCES; BONE DISEASES; MICROBIOLOGY; PATHOLOGY; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; BLASTOMYCES; BLASTOMYCOSIS; BONE DISEASES; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; TRIAZOLES;

EID: 84900494822     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.02.021     Document Type: Article

References (21)

1. Borgia S.M., Fuller J.D., Sarabia A., El-Helou P. Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen. Med Mycol 2006, 44(7):659-664.
2. Bradsher R.W. Histoplasmosis and blastomycosis. Clin Infect Dis 1996, 22(Suppl 2):S102-S111.
3. Chapman S.W., Dismukes W.E., Proia L.A., Bradsher R.W., Pappas P.G., Threlkeld M.G., et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008, 46(12):1801-1812.
4. Chapman S.W., Lin A.C., Hendricks K.A., Nolan R.L., Curriet M.M., Morris K.R., Turner H.R. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect 1997, 12(3):219-228.
5. Codifava M., Guerra A., Rossi G., Paolucci P., Lughetti L. Unusual osseous presentation of blastomycosis in an immigrant child: a challenge for European pediatricians. Ital J Pediatr 2012, 38(69):1-4.
6. Dismukes W.E., Bradsher R.W., Cloud G.C., Kauffman C.A., Chapman S.W., George R.B., et al. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med 1992, 93(5):489-497.
7. Farr R.C., Gardner G., Acker J.D., Brint J.M., Haglund L.F., Land M., et al. Blastomycotic cranial osteomyelitis. Am J Otol 1992, 13(6):582-586.
8. Freifeld A.G., Bariola J.R., Andes D. The role of second-generation antifungal triazoles for treatment of the endemic mycoses. Curr Infect Dis Rep 2010, 12(6):471-478.
9. Freifeld A., Proia L., Andes D., Baddour L.M., Blair J., Spellberg B., et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother 2009, 53(4):1648-1651.
10. Gray N.A., Baddour L.M. Cutaneous inoculation blastomycosis. Clin Infect Dis 2002, 34(10):E44-E49.
11. Hamann J.C., Marberry K. Sentinel presentation of disseminated Blastomyces dermatitidis infection as hip pain in a young adult: a case report. J Bone Joint Surg Am 2010, 92(2):469-472.
12. Kurtzman C.P., Robnett C.J. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997, 35:1216-1223.
13. Li R.K., Ciblak M.A., Nordoff N., Pasarell L., Warnock D.W., Mcginnis M.R. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother 2000, 44(6):1734-1736.
14. Oppenheimer M., Embil J.M., Black B., Wiebe L., Limerick B., Macdonald K., et al. Blastomycosis of bones and joints. South Med J 2007, 100(6):570-578.
15. Proia L.A., Harnisch D.O. Successful use of posaconazole for treatment of blastomycosis. Antimicrob Agents Chemother 2012, 56(7):4029.
16. Saccente M., Abernathy R.S., Pappas P.G., Shah H.R., Bradsher R.W. Vertebral blastomycosis with paravertebral abscess: report of eight cases and review of the literature. Clin Infect Dis 1998, 26(2):413-418.
17. Saccente M., Woods G.L. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev 2010, 23(2):367-381.
18. Saiz P., Gitelis S., Virkus W., Piasecki P., Bengana C., Templeton A. Blastomycosis of long bones. Clin Orthop Relat Res 2004, 421:255-259.
19. Sugar A.M., Liu X.P. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Antimicrob Agents Chemother 1996, 40(5):1314-1316.
20. Veligandla S.R., Hinrichs S.H., Rupp M.E., Lien E.A., Neff J.R., Iwen P.C. Delayed diagnosis of osseous blastomycosis in two patients following environmental exposure in nonendemic areas. Am J Clin Pathol 2002, 118(4):536-541.
21. Wagner D.K., Varkey B., Head M.D. Blastomycotic osteomyelitis of the mandible: successful treatment with ketoconazole. Oral Surg Oral Med Oral Pathol 1985, 60(4):370-371.